C4ORF36 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 8.30246982275185E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.03620026290241E-10 |
Normal-vs-Stage2 |
1.85849999834176E-08 |
Normal-vs-Stage3 |
2.8199664825479E-14 |
Normal-vs-Stage4 |
3.92907928414843E-13 |
Stage1-vs-Stage2 |
9.250400E-01 |
Stage1-vs-Stage3 |
1.76740000001896E-06 |
Stage1-vs-Stage4 |
2.321800E-03 |
Stage2-vs-Stage3 |
1.275580E-02 |
Stage2-vs-Stage4 |
5.433900E-02 |
Stage3-vs-Stage4 |
5.614200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.55371287952266E-12 |
Normal-vs-AfricanAmerican |
3.35950000041052E-07 |
Normal-vs-Asian |
1.560600E-01 |
Caucasian-vs-AfricanAmerican |
3.568800E-01 |
Caucasian-vs-Asian |
3.134800E-01 |
AfricanAmerican-vs-Asian |
3.225000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.18689519218651E-11 |
Normal-vs-Female |
3.17001980221221E-12 |
Male-vs-Female |
9.257500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.195700E-03 |
Normal-vs-Age(41-60Yrs) |
7.38387129217699E-12 |
Normal-vs-Age(61-80Yrs) |
1.5485945858984E-11 |
Normal-vs-Age(81-100Yrs) |
1.97640015464629E-10 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.849220E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.201800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.178100E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.106800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.371800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.432400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.716500E-02 |
Normal-vs-Grade 2 |
1.90199966887405E-10 |
Normal-vs-Grade 3 |
8.18123346846278E-13 |
Normal-vs-Grade 4 |
3.17634807345257E-13 |
Grade 1-vs-Grade 2 |
5.006800E-01 |
Grade 1-vs-Grade 3 |
2.669800E-01 |
Grade 1-vs-Grade 4 |
2.056000E-01 |
Grade 2-vs-Grade 3 |
8.356100E-03 |
Grade 2-vs-Grade 4 |
5.277200E-03 |
Grade 3-vs-Grade 4 |
3.974600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.63784566306913E-12 |
Normal-vs-ccB subtype |
2.59169996574826E-09 |
ccA subtype-vs-ccB subtype |
1.012000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.25089938407541E-11 |
Normal-vs-N1 |
4.69630001553867E-10 |
N0-vs-N1 |
3.238800E-01 |
|
|